Proposal to list medical devices supplied by Whiteley Corporation NZ Limited

Hospital devices Consultation Closed

Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.

What we’re proposing

Pharmac is seeking feedback on a proposal to list medical devices supplied by Whiteley Corporation NZ Limited (“Whiteley”) in Part III of Section H of the Pharmaceutical Schedule from 1 October 2023.

We propose to list medical devices supplied in the following category:

Consultation closes at 4pm Thursday 10 August 2023 and feedback can be emailed to

What would the effect be?

From 1 October 2023 medical devices supplied by Whiteley in the category above would be listed under a proposed national agreement for all Te Whatu Ora hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).

The Agreement would not be for sole supply and Te Whatu Ora hospitals could continue to purchase other supplier’s brands of sterilisation and decontamination equipment and associated consumable medical devices.

The Agreement would supersede any existing Te Whatu Ora agreements with Whiteley for products included in the Agreement. Any products listed in the Agreement and purchased by Te Whatu Ora hospitals would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing on the Pharmaceutical Schedule.

Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.

Who we think will be interested

  • Equipment validation service providers
  • Professional bodies
    • NZNO
    • Sterile Services Associated NZ
  • Suppliers and wholesalers
  • Te Whatu Ora staff including but not limited to:
    • Biomedical engineers (potentially involved in the validation process/outsourced)
    • Dental units
    • Facilities and support services department
    • General ward staff
    • Infection control department
    • Occupational health and safety department
    • Procurement and supply chain department
    • Sterile services department
    • Theatre staff

About the medical devices

Sterilisation and decontamination equipment and associated consumables (SDEAC)

SDEAC are medical devices used in surgical and non-surgical procedures primarily to achieve the disinfection and sterilisation of equipment and reusable medical devices. The products vary relating to their purpose, function, application, and clinical indication.

Why we’re proposing this

In August 2021 Pharmac issued a Request for Proposals (“RFP”) for the supply of sterilisation and decontamination equipment and associated consumables.

The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

Pharmac has been working with suppliers who responded to the RFP and were successful in being progressed to contract negotiation to seek provisional agreements. This proposal consists of the latest agreement to arise from these processes.

Details about our proposal

The proposal would result in listing 24 medical devices on the Pharmaceutical Schedule covering the below list of Whiteley’s brands:

  • Arid
  • Clinimax
  • Genesis
  • Instrumax Pink
  • Matrix
  • Medac
  • Medizyme
  • Microl
  • Opal
  • Pasac
  • Polaris
  • Proxy
  • Sonidet
  • Speedy
  • Viraclean
  • V-Wipes

Further information, including pricing and contractual details, have been provided to Te Whatu Ora Procurement personnel. Clinicians interested in further detail on what this change means for their Te Whatu Ora Hospital should engage with their Procurement teams.

To provide feedback

Send us an email: by 4pm 10 August 2023.

All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.

Your feedback may be shared

Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.

We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.